Mirum Pharmaceuticals, Inc.·4

Nov 3, 5:09 PM ET

Tucker Edwin Jonathan 4

4 · Mirum Pharmaceuticals, Inc. · Filed Nov 3, 2020

Insider Transaction Report

Form 4
Period: 2020-10-30
Tucker Edwin Jonathan
Chief Medical Officer
Transactions
  • Exercise/Conversion

    Stock Option (right to buy)

    2020-10-3025,00075,000 total
    Exercise: $7.70Exp: 2029-10-23Common Stock (25,000 underlying)
  • Exercise/Conversion

    Common Stock

    2020-10-30$7.70/sh+25,000$192,50031,000 total
Footnotes (2)
  • [F1]This Form 4 is being filed to report an option exercise and hold transaction that does not involve any open market purchase and sale.
  • [F2]1/4th of the shares vest one year after October 24, 2019 and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of October 24, 2019.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION